CAR T-Cell Therapy Market

CAR T-Cell Therapy Market Insights, Competitive Landscape, and Market Forecast - 2033

Published Date: May 2026 | Format: | No. of Pages: 203

Industry: Healthcare IT | Author Name: Sayali

Request Customisation / Information

The global market was valued at USD 7.2 Bn in 2026.

Novartis has been a pioneer in CAR T-cell Therapy.

The industry is estimated to witness a CAGR of 6% from 2026to 2033.

Increasing prevalence of blood cancer and regulatory support are driving the industry.

A key opportunity lies in rising investments by government bodies to enhance research.

Quality assured

Confidentiality assured

Custom research services